|

The TRICURE US IDE Pivotal Study

RECRUITINGN/ASponsored by TRiCares
Actively Recruiting
PhaseN/A
SponsorTRiCares
Started2026-07-08
Est. completion2031-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The purpose of the study is to evaluate safety and effectiveness of the TRiCares Topaz TTVR system for treatment of subjects presenting with clinically relevant tricuspid regurgitation who are suitable for valve replacement.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient is ≥ 18 years of age
* Patient has severe or greater tricuspid regurgitation with symptoms despite optimal medical therapy
* Patient is an appropriate candidate to undergo TTVR as determined by the Institution Heart Team

Exclusion Criteria:

* Patient has a tricuspid device currently in place
* Patient has anatomical contraindications
* Patient is in need of urgent surgery
* Patient has a left ventricular ejection fraction of \< 25%
* Patient has life expectancy of \< 1 year

Conditions2

Heart DiseaseTricuspid Regurgitation (TR)

Locations1 site

Piedmont Heart Institute

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.